'Friends of Cancer Research' Will Lead New Public Education Campaign

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 9
Volume 5
Issue 9

BETHESDA, Md--As part of its resolution commemorating the 25th anniversary of the National Cancer Act, the National Cancer Advisory Board (NCAB) has voted to initiate a 1-year public education program to reaffirm the national commitment to cancer research.

BETHESDA, Md--As part of its resolution commemorating the 25thanniversary of the National Cancer Act, the National Cancer AdvisoryBoard (NCAB) has voted to initiate a 1-year public education programto reaffirm the national commitment to cancer research.

Leading the campaign will be the newly formed Friends of CancerResearch, an organization that includes almost every US cancergroup. Dr. Ellen Sigal, PhD, president of Sigal Environmentaland a member of the NCAB subcommittee on basic and environmentalcancer research, will head the new group.

The goal of the campaign is to mobilize public support for cancerresearch, by meeting the following objectives:

  • Demonstrating the benefits of cancer research.
  • Illustrating the need for answers to the disease.
  • Explaining the investment needed for the task ahead.

Said Dr. Sigal: "This year's 25th anniversary of the NationalCancer Act offers the fulcrum for a major, year-long public awarenesscampaign, combining news events and targeted media hits, thatwill build support for an enhanced national commitment to cancerresearch."

The educational campaign will be launched around September ata major cancer research center, and will have a message alongthe lines of "only research cures cancer."

Recent Videos
Patients with AML will experience different toxicities based on the treatment they receive, whether it is intensive chemotherapy or targeted therapy.
A younger patient with AML who is more fit may be eligible for different treatments than an older patient with chronic medical conditions.
Breast cancer care providers make it a goal to manage the adverse effects that patients with breast cancer experience to minimize the burden of treatment.
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Genetic backgrounds and ancestry may hold clues for better understanding pancreatic cancer, which may subsequently mitigate different disparities.
Factors like genetic mutations and smoking may represent red flags in pancreatic cancer detection, said Jose G. Trevino, II, MD, FACS.
Thomas Hope, MD, believes that an NRC initiative to update infiltration guidelines may organically address concerns that H.R. 2541 outlines.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
4 experts are featured in this series.
4 experts are featured in this series.
Related Content